Assessment of the outcomes after using the liaison critical pathway of in patients with diabetes mellitus

Abstract

Outcomes of the liaison critical pathway for diabetes mellitus are measured by good control of blood glucose, prevention of complications and non-interruption. Between May 2010 and December 2012, the liaison critical pathway was used in 70 patients (36 male and 34 female patients), with an average age of 66.5 years, disease duration of 8.4 years, and HbA1c (NGSP) of 9.3%. While treatment was interrupted in 5 patients during the observation, treatment was resumed in all these patients. HbA1c significantly decreased from 9.4 ± 0.3 % (mean ± SE ) on the day before the treatment using the liaison critical pathway to 6.8 ± 0.1 % at 6 months and 7.0 ± 0.1 % at 1 year after the treatment in 56 patients. An occurrence or aggravation of diabetic complications was observed in 5 patients, and these patients were treated with suitable medication and have since recovered. The liaison critical pathway may be useful for diabetes treatment and care in our city.